【4 月 28 日,云顶新耀宣布重大变动!】2025 年 4 月 28 日,云顶新耀是专注创新药研发等的生物制药公司。其已满足港交所上市规则第 8.05 条的市值/收益要求,股份简称中的“B”标记于 2025 年 4 月 22 日获批移除,相关变更自 2025 年 5 月 2 日生效。云顶新耀作为沪深港通下港股通标的,此次股份简称“B”标记的移除,表明公司在市值和收入等达主板上市企业要求。自 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.